What is the P/E ratio of NEXGENRX INC. (NXG.V)?

The trailing price-to-earnings (P/E) ratio of NEXGENRX INC. is 21.0.

Does NEXGENRX INC. (NXG.V) pay a dividend?

Yes, NEXGENRX INC. pays an annual dividend of 0.01 CAD, yielding 2.38%.

What is the market capitalization of NEXGENRX INC.?

NEXGENRX INC. (NXG.V) has a market capitalization of approximately 30,580,367 CAD.

Where can I buy NXG.V in Canada?

NXG.V can be purchased through any Canadian online broker including Wealthsimple, Questrade, Qtrade, or RBC Direct Investing.

NXG.V

NEXGENRX INC.

NEXGENRX INC. (NXG.V) is a Canadian company in the healthcare sector, listed on TSXV. Market capitalization of 31 million CAD (micro-cap).

Details

Price0.43 CAD

Market cap30.58 M CAD

Dividend yield2.38%

Annual rate0.01 CAD

Payout ratio62.50%

Next ex-dateApr 24, 2026

ROE23.51%

Debt / Equity3.92%

SectorHealthcare

Websitenexgenrx.com

Updated a few minutes ago

NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. The company offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. It also provides proprietary computer software, and ancillary services. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.